Literature DB >> 26347329

Mefenamic acid: A possible cause of drug-induced acute pancreatitis.

S Wurm1, F Schreiber1, W Spindelboeck2.   

Abstract

INTRODUCTION: Drug-induced acute pancreatitis (AP) is rare, but as there are no systematic data on it, the true incidence is not known. CASE REPORT: This case report is a first description of two episodes of AP occurring after administration and subsequent re-administration of mefenamic acid to a young woman without comorbidities. Other common causes of AP could be ruled out. With both episodes, the latency of AP was less than 24 h after drug intake.
CONCLUSION: Mefenamic acid should be considered as a possible cause of drug-induced AP.
Copyright © 2015 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Classification of drug-induced AP; Drug-induced acute-pancreatitis; Idiosyncratic drug reaction; Mefenamic acid; NSAIDs

Mesh:

Substances:

Year:  2015        PMID: 26347329     DOI: 10.1016/j.pan.2015.08.003

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  3 in total

1.  Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.

Authors:  Fariborz Mansour-Ghanaei; Farahnaz Joukar; Zahra Taherzadeh; Homayoon Sokhanvar; Tolou Hasandokht
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

2.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

3.  The Risk of Acute Pancreatitis and Selective Serotonin Reuptake Inhibitors Use: A Meta-Analysis of Case-Control Studies.

Authors:  Shih-Wei Lai; Cheng-Chan Yu; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Dose Response       Date:  2020-03-30       Impact factor: 2.658

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.